Trial intelligence / Profile preview

LMWH plus mechanical prophylaxis vs mechanical prophylaxis alone in abdominopelvic surgery

TCTR20210525006Phase 4Terminated

Sponsor
Ramathibodi Hospital
Start
Jul 2018
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of low molecular weight heparin calcium in venous thromboembolism (VTE), sponsored by Ramathibodi Hospital. Started Jul 2018; status: terminated.

02

Drugs

low molecular weight heparin calcium
03

Conditions

venous thromboembolism (VTE)

Beyond the preview

Go deeper on TCTR20210525006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210525006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call